Catalyst Biosciences (FRA:HGF2) Total Long-Term Liabilities : €4.37 Mil (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Catalyst Biosciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Catalyst Biosciences's Total Long-Term Liabilities for the quarter that ended in Sep. 2023 was €4.37 Mil.

Catalyst Biosciences Total Long-Term Liabilities Historical Data

The historical data trend for Catalyst Biosciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalyst Biosciences Total Long-Term Liabilities Chart

Catalyst Biosciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Long-Term Liabilities

Get a 7-Day Free Trial

0.15

1.19

0.81

0.36

31.44

Catalyst Biosciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Long-Term Liabilities	Get a 7-Day Free Trial															-	31.44	35.36	35.00	4.37

Catalyst Biosciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Catalyst Biosciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Catalyst Biosciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Catalyst Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Biosciences Inc (FRA:HGF2) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 Gateway Boulevard, Suite 710, South San Francisco, CA, USA, 94080

Website

https://www.catalystbiosciences.com

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Catalyst Biosciences Headlines

No Headlines